John Paulson’s Q3 2025 13F portfolio surged to ~$2.97B, concentrated in just 10 securities, with Madrigal Pharma (MDGL) as the largest position. MDGL, now ~30% of the portfolio, was trimmed by ~9% but ...
Paid non-client promotion: Affiliate links for the products on this page are from partners that compensate us (see our advertiser disclosure with our list of partners for more details). However, our ...
ST. HELENA, Calif.--(BUSINESS WIRE)--The Duckhorn Portfolio, Inc. (NYSE: NAPA) (the “Company”) announced today that it has entered into distribution agreements with Republic National Distributing ...
John Paulson's Paulson & Company 13F portfolio rose to ~$2.01B in Q2 2025, concentrated in 15 securities with top holdings in MDGL, PPTA, AAMI, BHC, and NG. Madrigal Pharma remains the largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback